Aberrant regulation of phosphoinositide 3-kinase (PI3K) activity is implicated in various diseases such as cancer and diabetes. Thus, high-throughput screening (HTS) of small-molecule inhibitors for PI3 kinases is an appealing strategy for drug development. Despite the attractiveness of lipid kinases as drug targets, screening for inhibitors for PI3K activities has been hampered by limited assay formats adaptable for HTS. The authors describe a homogeneous, direct, and nonradioactive assay for highly sensitive detection of PI3Kα, β, δ, and γ activities, which is suitable for HTS. The assay is based on fluorescence superquenching of a conjugated polymer upon metal-ion-mediated association of phosphorylated and dye-labeled substrates. As a result of phosphorylation, quencher and polymer are brought into proximity, and fluorescent energy transfer occurs. This event can be monitored as either fluorescence quench of the polymer or as enhanced emission from the quencher. Ratiometric analysis of the wavelengths eliminates interferences from autofluorescing compounds, which are present in HTS libraries. The platform has been adapted for the 384-well microplate format and delivers Z factors of > 0.6 at substrate conversions as low as 7%. Using this assay platform, several unreported inhibitors and activators of PI3Ks were identified in an 84compound screen. (Journal of Biomolecular Screening 2006:413-422) Journal of Biomolecular Screening 11(4); 2006 www.sbsonline.org 417 FIG. 3. Enzyme concentration curves for phosphoinositide 3-kinase α (PI3Kα) in various read-out modes. Decreasing concentrations of PI3Kα were reacted, and experimental wells were monitored at emission wavelengths of (a) 490 nm, (b) 574 nm, (c) 574 nm/490 nm, or (d) 490 nm/574 nm after excitation of samples at 450 nm. Data are presented as relative fluorescence units (RFU; left panel) or converted data (middle panel). Calibrator curves used to determine product conversions are shown in the right panel. Error bars represent the standard deviation from the mean of 3 replicates. Stankewicz and Rininsland 420 www.sbsonline.org Journal of Biomolecular Screening 11(4); 2006 FIG. 5. Determination of IC 50 values for positive hits: IC 50 values were obtained for 8 novel inhibitors and 1 reported inhibitor. The delta relative fluorescence units (RFU) between reactions in the presence or absence of enzyme were obtained and used to calculate percent inhibition. Error bars represent the standard deviation from the mean of 3 replicates.
INTRODUCTION
P ROTEIN KINASES ACT AS REGULATORS of signal cascades that are central to cellular growth, differentiation, and proliferation. These enzymes transfer a phosphate group from adenosine triphosphate (ATP) to 1 or more sites in a specific substrate protein. 1 The phosphoinositide 3-kinase (PI3K) family of kinases is considered a "master control switch" in the control of cellular processes. Several external cellular growth factors, such as epidermal growth factor receptor, insulin receptor, and G-protein-coupled receptors, signal directly through PI3Ks. Class I PI3Ks are divided into 2 subclasses, IA and IB, on the basis of their mechanisms of activation. The 4 class I PI3Ks currently known (p110α, β, δ, and γ) phosphorylate the 3-hydroxyl group of the inositol ring of phosphatidylinositol (PtdIns), PtdIns(4)P, and PtdIns(4,5)P 2 to form PtdIns(3)P, PtdIns(3,4)P 2 , and PtdIns(3,4,5)P 3 (also called PIP3). PIP3 binds to a variety of effector molecules, including serine-threonine kinases, tyrosine kinases, and regulators of Gproteins. These molecules control cell growth and proliferation, prevent apoptosis, and mediate the metabolic actions of insulin. The distinct biological functions of proteins regulated by PI3Ks have identified the PI3Ks as promising targets for development of drugs against cancer, diabetes, and inflammatory and immunological diseases. 2 For high-throughput screening (HTS) of compounds that inhibit enzymatic activity, methods are most amenable that are nonradioactive, are of addition-only type, and direct and allow detections of less than 10% substrate conversions. Methods to directly measure PI3K activity involve monitoring of incorporated radioactive ATγP 32 . 3 These assays are heterogeneous and not desirable for reasons of safety and cost. More recently, fluorescence-based assays have begun to replace radioactive methods and include fluorescence polarization (FP) 4 and time-resolved fluorescence resonance energy transfer (TR-FRET). 5 These assays are typically competitive and based on binding of fluorescent-labeled PIP3 probe and phosphorylated products to a detector protein such as an antibody or the Pleckstrin homology domain. 6 Because detector proteins vary in their binding affinity with different PI3K substrates, this approach cannot be equally applied to the various isoforms of PI3Ks.
We have recently introduced a universal and homogeneous platform for direct and highly sensitive detection of kinase and phosphatase activities using fluorescence superquenching. 7 This phenomenon is based on the fact that small molecules capable of serving as electron or energy quenchers for the polymer can extinguish fluorescence of hundreds to a thousand of polymer repeat units (PRUs). 8 The PRUs are conjugated to form a backbone of modified anionic polyelectrolyte poly (p-phenylene-ethynylene) (PPE) derivatives, in which unsaturated π electrons form strong absorption bands and convey to the material the properties of semiconductors. The kinase sensor platform is composed of a fluorescent polymer colocated with phosphate-coordinating metal ions on the surface of microspheres. Upon phosphorylation by an appropriate kinase, the substrate binds to the polymer via association of phosphoryl groups with the metal ions, and fluorescence is quenched (Fig. 1) . The advantage of superquenching is that the amplified signal can result in sensitivities that are higher than the sensitivity obtained in assays based on FRET and FP and are similar to the sensitivities obtained with radioactive assays.
The superquenching platform is adaptable to various types of substrates types, including phosphorylated proteins, 9 peptides, 7 and nucleotides. 10 This broad application, the ability to miniaturize, and high sensitivity make this platform attractive for HTS. However, the spectral characteristics of the polymer make it susceptible to interference by compounds that autofluoresce or quench emission. Most fluorescent assays are susceptible to interference, and because these interfering factors show greater effects at wavelengths between 300 and 500 nm, fluorescence assays based on FP and FRET have recently employed fluorescence probes with longer wavelengths. 11 This approach cannot be applied to the fluorescence superquenching platform because the emission band of the sensor at 490 nm is inherent to the chemical structure of the polymer. Our strategy for overcoming compound interference was by monitoring enhanced emission of a quencher that has spectral overlap with the emission band of the polymer. The ratiometric evaluation of fluorescence quench and enhanced emission was predicted to normalize for compounds that nonspecifically quench florescence.
Here we describe highly sensitive assays for the detection of class I PI3K activities that meet requirements for HTS. Second, we demonstrate ratiometric monitoring as an effective means in overcoming interferences from autofluorescent compounds in an 84compound inhibitor library. The limited screen identified several inhibitors and activators of enzyme activity and demonstrates that the assay format is a powerful tool for HTS screening of PI3Ktargeted compound libraries.
MATERIALS AND METHODS
PI3 kinases α, β, δ, and γ were purchased from Upstate (Lake Placid, NY). BODIPY-TMR-PtdIns and PtdIns(3)P were from Echelon (Salt Lake City, UT). An 84-kinase/phosphatase inhibitor compound library was purchased from Biomol (Plymouth Meeting, PA). Polystyrene functionalized beads were obtained from Interfacial Dynamics (Portland, OR) and coated with polymer poly(phenylene-ethynylene) as previously described. 7 Assay buffers were HEPES based, sterile filtered through a 0.2-µM cellulose membrane, and stored at 4°C. QTL sensor was prepared by QTL Biosystems and diluted 1:10 in sensor dilution buffer before use (100 mM MES based, pH 5.5).
Fluorescence quench and enhanced emission measurements
Fluorescence measurements were carried out using a Gemini XS plate reader (Molecular Devices, Sunnyvale, CA). Samples were excited using a wavelength of 450 nm. For monitoring in superquenching (turn-off) mode, an emission wavelength of 490 nm was used with a 475-nm cutoff filter. For monitoring in enhanced emission (turn-on) mode, a wavelength of 574 nm was used for emission with a 570-nm cutoff filter. For ratiometric analysis, dual-emission ratios of 574 nm/490 nm (for turn-on assays) or 490 nm/574 nm (for turn-off assays) were used. Data are presented as relative fluorescence units (RFU), percent phosphorylation, or as the ratios of 574 nm/490 nm or 490 nm/574 nm. Curve fit was performed using nonlinear regression (sigmoidal dose response, variable slope) with GraphPad Prism (San Diego, CA).
Phospho PtdIns calibrator curve
To quantify phosphorylated product, phospho PtdIns calibrator curves were prepared by combining phosphorylated PtdIns(3)P and nonphosphorylated PtdIns in various ratios (0%, 10%, 25%, 50%, and 100% PtdIns(3)P content) in a total volume of 15 µL of reaction buffer per well. Calibrator curves were established simul- taneously with the enzymatic reaction and used to convert RFU from experimental data to percent phosphorylation using SoftmaxPro software (Molecular Devices). For monitoring of activities for PI3Kα, β, and δ in superquenching mode, calibrators were used at concentrations of 1 µM and at 4 µM for PI3Kγ. Assays monitored in enhanced emission mode were performed with a 250 nM calibrator. QTL sensor was diluted 1:10 using sensor dilution buffer and 15 µL 1× sensor added to samples in wells of a 384-well white OptiPlate (PerkinElmer, Wellesley, MA) and incubated for 60 min at room temperature.
Optimization of the superquenching assays for PI3K , , , and
Unless otherwise specified, 5 mM dithiothreitol (DTT) was added to the assay buffer. For monitoring of activities for PI3Kα, β, and δ in superquenching mode, substrate was used at concentrations of 1 µM and 4 µM for PI3Kγ. Assays monitored in enhanced emission mode were performed with 250 nM substrate. Enzyme titrations were performed to establish EC 50 values. PI3Kα, β, and δ were diluted 2-fold from 42 nM to 10 pM in assay buffer containing 250 µM ATP. For PI3Kγ, enzyme concentrations ranged from 105 nM to 0.2 nM, and assays were performed with a final ATP concentration of 200 µM. Then, 10 µL of the enzyme mix was added to triplicate wells of a 384-well white OptiPlate. Substrate was diluted in assay buffer containing the appropriate concentration of ATP, and a volume of 5 µL was added to wells. Reactions were performed at room temperature for 60 min. QTL sensor was diluted 1:10 using sensor dilution buffer, and 15 µL 1× sensor was added to each well. Product formation was determined using Softmax Pro software (Molecular Devices).
Statistical parameters of the superquenching PI3K assay
For statistical evaluation of assays monitored in quench mode (450 nm excitation and 490 nm emission wavelengths), a total of 16 replicates for PI3Kα, β, and δ and 10 replicates for PI3Kγ were performed in the presence of varying concentrations of enzyme in the 10 µL assay buffer per triplicate well. To the enzyme mix, 5 µL substrate was added to achieve a final concentration of 1 µM for PI3Kα, β, and δ or 4 µM for PI3Kγ. The evaluation of PI3Kβ in 3 readout modes was performed as described above but with a final substrate concentration of 250 nM. Reactions proceeded at room temperature for 60 min and were terminated by addition of an equal volume of 1× sensor. Following incubation at room temperature for 60 min, samples were monitored using the appropriate wavelengths.
The quality of the PI3K assays was determined by the Z′ factor, 12 signal to background (S/B), signal to noise (S/N), percent coefficient of variation (%CV), and signal window (SW).
Determination of IC 50 values for Wortmannin and LY294002
Inhibition experiments were performed for each of the 4 PI3K isoforms in the presence of the known inhibitors Wortmannin and LY294002. Inhibitor solutions, enzyme solutions, and substrate/ ATP solutions were prepared as 3× concentrates in assay buffer and 5 µL each added to wells. Final Wortmannin inhibitor concentrations ranged from 9000 nM to 6 pM, and LY294002 concentrations were 66.7 µM to 125 pM for PI3Kα, β, and δ. For PI3Kα assays, a final enzyme concentration of 1.3 nM was used in the presence of 1 µM substrate and 50 µM ATP. For PI3Kβ, 3.9 nM enzyme was used with 1 µM substrate and 50 µM ATP, and PI3Kδ reactions were carried out using 2.6 nM enzyme in the presence of 1 µM substrate and 100 µM ATP. For inhibition of PI3Kγ, Wortmannin concentrations were 1000 nM to 61 nM, and LY294002 ranged from 320 µM to 19.5 nM. Reactions were carried out with final concentrations of 2.7 nM enzyme, 4 µM substrate, and 100 µM ATP.
Compound screen
Compounds present in an 84-kinase/phosphatase inhibitor library were diluted in DMSO and further diluted in assay buffer to achieve a final concentration of 5 µM. Substrate and ATP were combined and 10 µL added to wells for final concentrations of 250 nM and 50 µM, respectively. ATP was added near or below Km, which had previously been established as 64 µM, 52 µM, and 142 µM for PI3Kα, β, and δ, respectively. Final concentrations of PI3Kα, β, and δ were 1.3 nM, 3.9 nM, and 2.6 nM, respectively. These reaction conditions produced substrate conversions of 17%, as determined by back-calculation using a phospho PtdIns calibrator curve prepared simultaneously with the screen for PI3Kδ. Reactions containing enzyme in the absence of inhibitor and reactions in the absence of enzyme were used as controls and included on the same plate as the compounds. The final concentration of DMSO in all wells was 5.5% and within the range of DMSO tolerance, which had previously been determined to be 10%. The plate was incubated for 1 h at room temperature, and 15 µL of 1× sensor, diluted in sensor dilution buffer, was added. After 60-min incubation at room temperature, reactions were monitored using an excitation wavelength of 450 nm and emission wavelengths of 490 nm and 490 nm/574 nm. RFU and ratios of RFU were corrected for background fluorescence of the "no-enzyme" control and percent activity calculated based on the positive and negative controls. Hits were defined as compounds that inhibited PI3Kδ activity by 50% or more.
Determination of IC 50 values of positive "hits" identified in a compound screen
To determine IC 50 values of compounds identified as hits in the compound screen against PI3Kδ (PP1, PP2, KN-62, sphingosine,
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rottlerin, hypericin, RK-682, and palmitoyl-DL-carnitine Cl), inhibitor concentrations ranging from 150 µM to 146 nM were assayed using a final substrate concentration of 250 nM and 50 µM ATP. Reactions were monitored in ratiometric turn-off mode. Quercetin dihydrate concentrations ranged from 10 µM to 10 nM. To correct for nonspecific quench mediated by several of these colored compounds, compounds were titrated in the presence and in the absence of enzyme, and the difference in RFU was used to calculate percent inhibition.
RESULTS

Development of superquenching-based assays for PI3K , , , and
The PI3K assays used as substrates PtdIns, which did not contain phosphoryl groups in positions 4′ and 5′ of the inositol ring. This was a requirement to distinguish fluorescence quench between nonreacted lipid substrates and phosphorylated substrates. PtdIns(3)P was used as a calibrator to determine precise product formation. The reported suitability of unprimed PtdIns as substrates for class IA and class IB PI3 kinases 2 was demonstrated for all 4 kinases α, β, δ, and γ (Fig. 2) . Substrate conversions of~100% were obtained for PI3Kα, β, and δ with signal-to-background ratios of~8. PI3Kγ has significantly lower activity and produced 4% conversion with a signal-to-background ratio of 1.5.
Comparison of assay performance monitored in quench and enhanced emission mode
The BODIPY-TMR dye, which was used as a label for the substrate, demonstrated excellent capacity to serve as a quencher as well as energy transfer dye of the fluorescent polymer. This feature enabled the monitoring of assays in 4 different modes: 1) superquenching turn-off mode, 2) enhanced emission turn-on mode, 3) ratiometric turn-on mode, and 4) ratiometric turn-off mode. In an optimal assay, the raw RFU data correlate with the product conversion or can be calculated using calibration curves. Figure 3 demonstrates how accurate product formation can be determined in an enzyme concentration curve using calibration curves when single-wavelength or ratiometric turn-off modes are used. Alternatively, the ratiometric turn-on mode results in linear signal responses, and raw data correlate with product conversion so that calibration curves are not required.
The need for calibration of raw data when monitored in superquenching turn-off mode is the result of properties of the polymer, whereby the 1st quencher molecules that associate to the polymer lead to amplified superquenching of several hundred polymer repeat units per quencher molecule. This resulting biphasic quench signature makes it necessary to calculate accurate product formation or determine IC 50 values using calibration curves when data are monitored in single-wavelength modes or ratiometric turn-off modes, as demonstrated in Figure 3 . Figure  3a (right panel) shows a biphasic phospho PtdIns calibrator curve in which 45% of the signal is extinguished between 0% and 25% PtdIns when monitored in superquenching turn-off mode. EC 50 values derived from an enzyme concentration curve are slightly higher in the back-calculated data than in the raw RFU data When the identical data were monitored using enhanced emission turn-on mode (Fig. 3b) , a similar trend to data shown in Figure 3a is observed (EC 50 s are 1.47 nM compared to 2.9 nM). In this mode, 56% of signal is generated between 0% and 25% phospho PtdIns calibrator.
In contrast, when monitored in ratiometric turn-on mode (574 nm/490 nm) ( Fig. 3c) , the initial nonlinear signal responses in the phospho PtdIns calibrator curve that were observed when using the single-wavelength mode at 490 nm or 574 nm are normalized, and a linear correlation between converted and RFU data results. Thus, product conversion is directly correlated with RFU, as is demonstrated by the identical EC 50 values derived from raw RFU and converted data (5.2 nM in each case). The S/B increases~5-fold compared to assays monitored using single readout modes (21 vs. 4.4) ( Fig. 3c) .
When the experimental data were evaluated using ratiometric turn-off mode at 490 nm/574 nm (Fig. 3d) , the increased initial signal of the quench and enhanced emission modes is compounded. Although data analysis in this ratiometric mode produces large discrepancies in EC 50 values (0.5 nM and 7.1 nM raw RFU vs. back-calculated data), the readout provides for highly sensitive detection of low product conversions. The calibrator curve shows that 66.7% of the total signal is extinguished in the 1st portion of the curve, corresponding to~10% phosphorylated PtdIns.
In conclusion, the high S/B obtained at low product conversions with the ratiometric turn-off mode in addition to the ability to overcome compound interference (see Discussion below) makes this type of data analysis ideal for screening inhibitor libraries. For determination of potencies, the ratiometric turn-on mode is best suited because of the correlation of raw RFU and substrate conversions.
Robustness of the assay
A statistical parameter used in the drug screening community to evaluate the suitability of assays for HTS is expressed by the Z′ fac-tor. 12 An assay that delivers a Z′ factor > 0.5 is considered to be robust. The robustness of each PI3K assay was evaluated using multiples of reactions. The most sensitive assays were obtained when monitoring in the superquenching turn-off mode, with a final substrate concentration of 1 µM for PI3Kα, β, and δ and 4 µM for PI3Kγ. Therefore, these conditions were used first to establish the robustness of assays for PI3Kα, β, δ, and γ ( Table 1) . Z′ factors of 0.76, 0.67, and 0.73 were obtained for PI3Kα, β, δ, and γ, respectively, at a substrate conversion of 8%, 3%, and 7% with Z′ factors > 0.9 at maximal substrate conversions for all 3 isoforms. PI3Kγ has a very low turnover and resulted in a maximal substrate conversion of~4% ( Table 1) . Given the variability between 0% and 4%, phosphorylation conversions were not calculated. However, we were able to demonstrate that at concentrations of 25 nM and 12.5 nM PI3Kγ, Z′ factors of 0.6 and 0.5 could be obtained, and these are considered suitable for HTS.
Next, statistical parameters for the PI3Ks in 3 different monitor modes were determined using substrate concentrations of 250 nM, which were most suitable for ratiometric monitoring. Table 2 shows the statistical parameters of 1 representative kinase (PI3Kβ) obtained in 3 different modes of monitoring. The Z′ factor is slightly lower in assays with 250 nM substrate and monitored in ratiometric mode compared to assays using 1 µM substrate and monitored in the superquenching turn-off mode (Z′ factor = 0.61 at 7.3% conversion compared to 0.67 at 3% conversion) but is well within the range of an HTS-compatible assay.
Compound screen
The advantage of using ratiometric monitoring compared to single-wavelength monitoring in overcoming compound interference was evaluated by an 84-compound screen against PI3Kα, β, and δ. The number of library compounds that nonspecifically quenched fluorescence of the polymer was determined by screening the compounds against substrate and fluorescent polymer in the absence of enzyme (not shown). It was found that 22 compounds quenched emission of the QTL sensor, of which 20 were colored. Figure 4 shows results of an enzymatic screen against PI3Kδ in quench mode versus ratiometric turn-off mode. When monitored in superquenching turn-off mode, 8 compounds and the known inhibitors Wortmannin 13 and LY294002 14 inhibited enzyme activity by more than 50% (Fig. 4a) . These compounds (PP1, PP2, sphingosine, KN-62, palmitoyl-DL-carnitine, RK682) were confirmed as inhibitors in a follow-up screen (Fig.   5) , and inhibitor concentrations, which caused 50% inhibition of enzyme activity (IC 50 values), were determined ( Table 3) . Compounds, which quenched emission of the QTL sensor, nonspecifically caused an apparent "overrecovery" of activity ranging from 100% to 400% of the control (Fig. 4a) . As a result, the nonspecifically quenching compounds hypericin, rottlerin, and quercetin dihydrate, which are true inhibitors of enzyme activity ( Fig. 4b) , were not identified. In addition to causing false-negative hits, the overrecovery of signal masked the presence of an activator of PI3Kδ activity (tryphostin 23).
In ratiometric turn-off mode (490 nm/574 nm) ( Fig. 4b) , inhibitors resulted in increased RFU at 490 nm and decreased RFU at 574 nm. A ratio of > 4 for compounds that inhibited PI3Kδ activity by more than 50% was determined for 11 compounds ( Table 3) . Eight of these compounds were identical to the ones identified in Figure 4a , and the colored compounds hypericin, rottlerin, and quercetin dihydrate appeared as additional "hits." These compounds nonspecifically quenched emission of the QTL sensor but were identified as true inhibitors by ratiometric normalization. Table 3 illustrates how, in the presence of a compound that quenches RFU (monitored at a wavelength of 490 nm) and simultaneously inhibits enzyme activity, the compound-mediated nonspecific fluorescence quench is partially recovered by the inhibitor-mediated increase of RFU. Consequently, the effect of an inhibitor decreases the amount of transferred energy (monitored at a wavelength of 574 nm) in addition to the energy lost to the nonspecific quench event. As a result, ratios of > 4 (analyzed using the ratio of 490 nm/ 574 nm) were obtained for the compounds hypericin, rottlerin, and quercetin dihydrate, which were confirmed as true inhibitors in a follow-up screen (Fig. 5) .
When monitored in ratiometric turn-off mode, enzymatic activities did not increase over 100%, with the exception of the true activator tryphostin 25 (Fig. 4b) . Thus, this mode enables accurate detection of inhibitors as well as activators in this library screen.
The Z factor was calculated from the positive and negative control wells included on the compound plate ( Fig. 4b) and was 0.74 at a product conversion of 17%, indicating a robust assay. sion directly correlates to fluorescence signal. The advantage of the linear relationship between signal and product conversion is that percentages of phosphorylation can be derived precisely from raw RFU data without the need for calibrator curves or data manipulation. This is especially relevant when performing kinetic reactions (e.g., for time courses and for determining ATP K m ), where the nonlinear decrease in signal in the early part of the reaction must be corrected for with back-calculation when singlewavelength superquenching mode is used.
Monitoring of enhanced emission as opposed to fluorescence quench improved our current assay platform because a turn-on assay as opposed to turn-off assay is generated. Turn-off assays are intrinsically noisier than turn-on assays, which is reflected in an improved Z′ factor when a single-wavelength turn-on mode is used as opposed to the single-wavelength turn-off mode ( Table 3 ) (0.48 at 5.4% conversion compared to 0.3 at 5.4% conversion, respectively).
Compound interference was overcome by ratiometric evaluation of fluorescence. All 11 positive hits in an 84-compound screen against PI3Kδ were confirmed as true inhibitors in a follow-up screen for Wortmannin, LY294002, PP1, PP2, sphingosine, KN-62, RK 682, palmitoyl-DL-carnitine, hypericin, quercetin dihydrate, and rottlerin. The single-wavelength mode of our previous platform showed a 75% hit rate with 3 false negatives for the colored compounds hypericin, quercetin dihydrate, and rottlerin.
The observed IC 50 values for Wortmannin (18 nM) and LY294002 (767 nM) were close to reported values (4.2 nM for Wortmannin 13 and 500 nM to 1 µM for LY294002 14 ). The IC 50 value for quercetin dihydrate obtained with the ratiometric evaluation was 74 nM and 51-fold lower than the reported value of 3.8 µM. 15 This deviation may be attributable to the fact that the reported IC 50 value was obtained using significantly higher concentration of substrate (45 µM 15 ) and 1 µM ATP compared to 250 nM used in this study.
Because the PI3K isoforms are closely related but have distinct biological roles, effective and safe inhibitors are desired that are able to distinguish adequately the activities of different PI3K isoforms. Of the total of 14 inhibitors and 3 activators identified in the screen against PI3Kα, β, and δ, none of the compounds was specific for only 1 isoform. Preferential inhibition of PI3Kα and β by AG-879 was noted with no effect on PI3Kδ, and palmitoyl-DLcarnitine did not inhibit PI3Kβ but caused > 80% inhibition of PI3Kα and δ activities. Staurosporine preferentially inhibited PI3Kα, and sphingosine had approximately twice the inhibitory effect on PI3Kδ. Activators tryphostin 23, tryphostin 25, and GW5074 showed highest activation of PI3Kβ, PI3Kα, and PI3Kδ, respectively.
In summary, the kinase platform has been expanded to include lipids as additional substrates, providing the researcher with a method for enhancing the understanding of networks within the cell. The ability for overcoming compound interference makes the platform a promising new tool for HTS of inhibitors of diverse kinase and phosphatase activities.
